Birth Defects Research and Prevention Network

Birth Defects Research and Prevention Network is a consortium focused on surveillance, epidemiology, and prevention of congenital anomalies through multicenter studies and population-based registries. The Network brings together academic centers, public health agencies, and clinical programs to study causes, outcomes, and prevention strategies for birth defects using coordinated protocols and standardized data collection. Participants include investigators from institutions and agencies across the United States and collaborations with international partners in Europe, Canada, and Australia.

Overview

The Network conducts population-based surveillance and case-control studies drawing investigators from Centers for Disease Control and Prevention, National Institutes of Health, Johns Hopkins University, Harvard University, and University of California, San Francisco while engaging clinical collaborators from Boston Children's Hospital, Mayo Clinic, Cincinnati Children's Hospital Medical Center, Children's Hospital of Philadelphia, and Stanford University Medical Center. Its activities integrate expertise from epidemiologists linked to Columbia University, University of Washington, Yale University, University of Texas Southwestern Medical Center, and University of North Carolina at Chapel Hill alongside geneticists from Broad Institute, Washington University in St. Louis, University of Michigan, University of Pennsylvania, and Duke University. Public health partners include state health departments such as California Department of Public Health, New York State Department of Health, Texas Department of State Health Services, and international agencies like Public Health England and Health Canada.

History and Development

The Network emerged during efforts in the 1990s to harmonize congenital anomaly surveillance modeled after programs at Centers for Disease Control and Prevention and influenced by work at March of Dimes and academic centers such as University of Iowa, University of Minnesota, University of Pittsburgh, Emory University, and University of Alabama at Birmingham. Early studies drew upon methods from case-control investigations associated with Harvard University, Yale University, and Johns Hopkins University and were informed by teratology research at National Institute of Child Health and Human Development, National Institute of Environmental Health Sciences, and Food and Drug Administration. Over time the Network expanded through collaborations with registries at Queen Mary University of London, Karolinska Institutet, University of Toronto, University of Sydney, and Monash University.

Organization and Governance

Governance structures include steering committees and scientific advisory boards with representatives from National Institutes of Health, Centers for Disease Control and Prevention, March of Dimes, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, and academic members from Columbia University, Johns Hopkins University, Harvard University, University of California, San Diego, and University of North Carolina at Chapel Hill. Data management and biostatistics support derive from groups at Fred Hutchinson Cancer Research Center, Vanderbilt University, University of Michigan, University of Pennsylvania, and University of Washington. Ethical oversight involves institutional review boards at Stanford University, Massachusetts General Hospital, Children's Hospital Boston, and Mount Sinai Health System, with legal and policy input from Georgetown University and Boston University.

Research Activities and Methods

Methodologies include population-based surveillance modeled after protocols from Centers for Disease Control and Prevention, case-control designs influenced by researchers at Harvard University School of Public Health, genetic epidemiology using platforms from Broad Institute and Wellcome Sanger Institute, and bioinformatics pipelines developed in collaboration with University of California, Berkeley, Massachusetts Institute of Technology, Carnegie Mellon University, and University of Toronto. Studies examine environmental exposures evaluated in contexts similar to work at National Institute of Environmental Health Sciences, pharmacologic teratology linked to investigations from Food and Drug Administration and National Institutes of Health, and prenatal care patterns informed by American College of Obstetricians and Gynecologists recommendations. Data linkage efforts connect birth registries with hospital discharge systems at New York State Department of Health and vital records offices used by California Department of Public Health and Texas Department of State Health Services.

Major Findings and Impact

The Network contributed evidence on associations between maternal exposures and specific congenital anomalies, aligning with findings reported by National Institutes of Health, Centers for Disease Control and Prevention, and academic teams at Johns Hopkins University, Harvard University, Yale University, and University of Washington. Its work informed clinical guidance from American College of Obstetricians and Gynecologists and public health initiatives supported by March of Dimes and World Health Organization recommendations, and influenced surveillance standards used by Public Health England and Health Canada. Outcomes include contributions to risk estimates for neural tube defects paralleling folic acid policy shifts endorsed by United States Department of Agriculture, Food and Drug Administration, and Centers for Disease Control and Prevention and insight into cardiac defect epidemiology consistent with research at Cleveland Clinic, Mayo Clinic, University of Michigan, and Children's Hospital of Philadelphia.

Collaborations and Funding

Funding and partnerships have involved federal agencies including National Institutes of Health, Centers for Disease Control and Prevention, Agency for Toxic Substances and Disease Registry, philanthropic organizations such as March of Dimes and Bill & Melinda Gates Foundation, and academic grants from institutions like Johns Hopkins University and Harvard University. International research collaborations include teams at Karolinska Institutet, University of Oxford, University of Toronto, University of Melbourne, and Imperial College London, with data-sharing relationships negotiated among state health departments including California Department of Public Health and New York State Department of Health.